|
Structure-function of Glycosaminoglycan
Receptors and Hyaluronic Acid Synthases and their roles in human
diseases.
Our
laboratory has a broad interest in how glycosaminoglycans like
hyaluronic acid (HA) function normally in the body and how they
are involved in human diseases. The following two main projects
are funded by separate NIH grants:
1)
”Structure-Function of the HA Receptor for Endocytosis” NIH
GM69961
Abstract
(link to pdf file)
HA is a
major part of extracellular matrices throughout the body, and
plays both structural and cell signaling roles in various
tissues. For example, HA can regulate cell behavior and
migration during development. Humans synthesize and degrade
about 5 grams of HA every day. Sinusoidal endothelial cells in
lymph node and liver have a specific endocytic receptor for HA
that mediates its clearance, and degradation, from lymph fluid
or the blood, respectively. Due to the high viscosity of HA, the
failure to remove circulating HA would be harmful. Recent
results suggest that variants of this HA Receptor for
Endocytosis (HARE) may have important functions during
development, lymphocyte movement in the body and during
metastasis of cancer cells. We have purified and cloned this
human membrane receptor and are using molecular biology, cell
biology and protein chemistry techniques to understand how it
interacts with HA and other glycosaminoglycans. We are also
collaborating with others to determine the role of HARE in
various diseases, including cancer.
2)
“Structure-Function of Hyaluronan Synthases” NIH GM35978
lAbstract (link
to pdf file)
HA
synthesis and degradation are abnormal in many diseases, such as
arthritis and many cancers. Since we cloned the first HA
synthase gene, which encodes the enzyme that makes hyaluronic acid, we have
been using recombinant DNA approaches, such as site-directed
mutagenesis, to understand how the enzyme catalyzes the
alternating polymerization of two different sugars into a
polymer of ≥30,000 monomers. Although the three human HA
synthases are involved in many important normal and disease
processes, no one has been able to purify and study these
proteins in an active form. That is one of our major goals. We
are studying the streptococcal HA synthases as a model, in order
to solve this problem so we can advance our understanding about
the role of HA synthases in human health and disease.
Last
updated: March 8, 2005
Abbreviated
NIH Biosketch for Dr. Weigel (3/2/05).
Biosketch
List of
publications from the Weigel research group since 2002.
Publications
Full CV for
Dr. Weigel.
CV
|